| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.27B | 75.11B | 67.38B | 59.76B | 53.04B | 47.71B |
| Gross Profit | 9.92B | 9.14B | 7.52B | 6.48B | 6.22B | 6.21B |
| EBITDA | 9.25B | 8.87B | 7.28B | 6.28B | 6.45B | 6.58B |
| Net Income | 3.80B | 2.80B | 2.31B | 2.25B | 2.87B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 225.21B | 210.32B | 211.91B | 166.78B | 159.08B | 147.10B |
| Cash, Cash Equivalents and Short-Term Investments | 19.55B | 20.50B | 17.39B | 15.14B | 18.22B | 8.70B |
| Total Debt | 76.19B | 76.32B | 78.08B | 60.12B | 57.12B | 43.86B |
| Total Liabilities | 122.56B | 116.13B | 118.11B | 89.38B | 84.16B | 70.86B |
| Stockholders Equity | 102.22B | 93.75B | 93.41B | 76.99B | 74.58B | 75.94B |
Cash Flow | ||||||
| Free Cash Flow | 2.32B | 7.39B | -6.63B | 760.00M | -1.22B | -5.28B |
| Operating Cash Flow | 11.48B | 13.01B | 5.88B | 6.55B | 4.71B | 3.94B |
| Investing Cash Flow | -9.60B | -6.82B | -15.77B | -11.89B | -6.86B | -9.76B |
| Financing Cash Flow | 2.43B | -3.32B | 12.03B | 2.12B | 11.43B | 6.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.66B | 15.74 | ― | 1.49% | 1.23% | 0.12% | |
68 Neutral | ¥10.25B | 7.54 | ― | 0.67% | 31.76% | -25.89% | |
66 Neutral | ¥68.85B | 12.14 | ― | 2.18% | 12.03% | 30.12% | |
65 Neutral | ¥40.92B | 18.51 | ― | 2.59% | 4.02% | 18.12% | |
65 Neutral | ¥18.39B | 30.65 | ― | 1.13% | 3.37% | 9.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥6.21B | 19.21 | ― | 2.29% | 0.08% | 105.25% |